Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Palmer

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Virology|December 15, 2005
Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenovirusesWeidong Xiong, Shyam Goverdhana, Sandra A Sciascia, et al.
Journal of Virology|April 9, 2010
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeuticsMariana Puntel, A K M G Muhammad, Marianela Candolfi, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 3, 2022
Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation StudyHelena Voetterl, Guido van Wingen, Giorgia Michelini, et al.
Toxicology and Applied Pharmacology|February 14, 2013
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaMariana Puntel, Ghulam Muhammad A K M, Catherine Farrokhi, et al.
American Journal of Human Genetics|May 1, 2012
Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduriaSandesh C S Nagamani, Philippe M Campeau, Oleg A Shchelochkov, et al.
Neuro-Oncology|May 25, 2007
Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitroMarianela Candolfi, G Elizabeth Pluhar, Kurt Kroeger, et al.
Molecular Therapy. Advances|May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV preventionChang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Virology|December 15, 2005
Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenovirusesWeidong Xiong, Shyam Goverdhana, Sandra A Sciascia, et al.
Journal of Virology|April 9, 2010
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeuticsMariana Puntel, A K M G Muhammad, Marianela Candolfi, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 3, 2022
Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation StudyHelena Voetterl, Guido van Wingen, Giorgia Michelini, et al.
Toxicology and Applied Pharmacology|February 14, 2013
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaMariana Puntel, Ghulam Muhammad A K M, Catherine Farrokhi, et al.
American Journal of Human Genetics|May 1, 2012
Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduriaSandesh C S Nagamani, Philippe M Campeau, Oleg A Shchelochkov, et al.
Neuro-Oncology|May 25, 2007
Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitroMarianela Candolfi, G Elizabeth Pluhar, Kurt Kroeger, et al.
Molecular Therapy. Advances|May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV preventionChang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.
Pageof 5